MOBILE, Ala.--(BUSINESS WIRE)--Nov 7, 2024--
TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the third quarter and nine months ended September 30, 2024.
Third Quarter 2024 Highlights*
All comparisons are to the quarter ended September 30, 2023, unless otherwise noted
*As of the third quarter of 2024, TruBridge is now reporting two segments in its financial statements representing the two business units. Financial Health represents the previous Revenue Cycle Management (RCM) segment, and Patient Care represents the previously reported Electronic Health Record (EHR) segment, including the patient engagement business.
Commenting on the results, Chris Fowler, chief executive officer of TruBridge, Inc., stated, “We are pleased with the strong results our team delivered this quarter. Our Financial Health business is showing solid growth and adjusted EBITDA margin is expanding as anticipated. On a recent trip to India, I was able to witness firsthand the impressive work our team is doing to successfully execute the Viewgol integration. I am happy to report that everything is moving along smoothly, and we remain focused on optimizing operations and realizing margin improvements over time.
“Our recently launched analytics offering is starting to resonate with our initial customers, and we believe that, over time, it has the potential to become a contributor to our growth strategy. We have delivered consistent results so far in 2024, made steady progress on our ongoing initiatives and generated bookings and a pipeline that give us confidence in our outlook as we move into 2025,” concluded Fowler.
Executive Leadership Changes
TruBridge also announced today the elevation of the Company’s business unit general managers to report directly to the Company’s Chief Executive Officer, reflecting the expanded scope and evolution of these roles. In conjunction with this move, David Dye will be retiring from his role as Chief Operating Officer, effective December 31, 2024, at which time the Company will eliminate that position. He will serve the remainder of his board term through completion in 2026. Dye has been with the Company since 1990, having held many roles in addition to his current position, including Chairman, Chief Growth Officer, President and Chief Executive Officer, and Chief Financial Officer.
Glenn Tobin, chairman of the Company’s Board of Directors, added, “On behalf of our Board of Directors and the entire TruBridge organization, I want to express my appreciation for David and his decades of contribution. David’s leadership and numerous accomplishments have been integral to TruBridge’s success, and his positive impact has been felt by many employees over the years.”
Financial Guidance
For the fourth quarter of 2024, TruBridge expects to generate:
For the full year 2024, TruBridge expects to generate:
Conference Call
TruBridge will hold a conference call and live webcast to discuss third quarter 2024 results on Friday, November 8, 2024, at 8:00 a.m. Central time/9:00 a.m. Eastern time. To access this interactive teleconference, dial (877) 407-0890 and request connection to the TruBridge earnings conference call. A 30-day online replay will be available approximately one hour following the conclusion of the live webcast. To listen to the live webcast or access the replay, visit the Company’s investor relations website, investors.trubridge.com.
About TruBridge
We are a trusted partner to more than 1,500 healthcare organizations with a broad range of technology-first solutions that address the unique needs and challenges of diverse communities, promoting equitable access to quality care and fostering positive outcomes. TruBridge has over four decades of experience in connecting providers, patients and communities with innovative data-driven solutions that create real value by supporting both the financial and clinical side of healthcare delivery. Our industry leading HFMA Peer Reviewed® suite of revenue cycle management (RCM) offerings combine unparalleled visibility and transparency to enhance productivity and support the financial health of healthcare organizations across all care settings. We support efficient patient care with electronic health record (EHR) product offerings that successfully integrate data between care settings. Above all, we believe in the power of community and encourage collaboration, connection, and empowerment with our customers. We clear the way for care. For more information, please visit www.trubridge.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as “expects,” “anticipates,” “estimates,” “believes,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,” “will” and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the Company’s future financial and operational results are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements.Such factors may include: saturation of our target market and hospital consolidations; unfavorable economic or market conditions that may cause a decline in spending for information technology and services; significant legislative and regulatory uncertainty in the healthcare industry; exposure to liability for failure to comply with regulatory requirements; pandemics and other public health crises and related economic disruptions; transition to a subscription-based recurring revenue model and modernization of our technology; competition with companies that have greater financial, technical and marketing resources than we have; potential future acquisitions that may be expensive, time consuming, and subject to other inherent risks; our ability to attract and retain qualified client service and support personnel; disruption from periodic restructuring of our sales force; potential delay in the development of markets for our RCM service offering; potential inability to properly manage growth in new markets we may enter; potential disruption of our business due to our ongoing implementation of a new enterprise resource planning software solution; exposure to numerous and often conflicting laws, regulations, policies, standards or other requirements through our international business activities;potential litigation against us; our reliance on an international workforce which exposes us to various business disruptions; our utilization of artificial intelligence, which could expose us to liability or adversely affect our business if we cannot compete effectively with others using artificial intelligence; potential failure to develop new products or enhance current products that keep pace with market demands; failure of our products to function properly resulting in claims for medical and other losses; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases free of undetected errors or problems; failure to convince customers to migrate to current or future releases of our products; failure to maintain our margins and service rates; increase in the percentage of total revenues represented by service revenues, which have lower gross margins; exposure to liability in the event we provide inaccurate claims data to payors; exposure to liability claims arising out of the licensing of our software and provision of services; dependence on licenses of rights, products and services from third parties; misappropriation of our intellectual property rights and potential intellectual property claims and litigation against us; interruptions in our power supply and/or telecommunications capabilities, including those caused by natural disaster; potential inability to secure additional financing on favorable terms to meet our future capital needs; our substantial indebtedness, and our ability to incur additional indebtedness in the future; pressures on cash flow to service our outstanding debt; restrictive terms of our credit agreement on our current and future operations; changes in and interpretations of financial accounting matters that govern the measurement of our performance; significant charges to earnings if our goodwill or intangible assets become impaired; fluctuations in quarterly financial performance due to, among other factors, timing of customer installations; volatility in our stock price; failure to maintain effective internal control over financial reporting; inherent limitations in our internal control over financial reporting; vulnerability to significant damage from natural disasters; market risks related to interest rate changes; potential material adverse effects due to macroeconomic conditions, including bank failures or changes in related regulation; and other risk factors described from time to time in our public releases and reports filed with theSecurities and Exchange Commission, including, but not limited to, our most recent Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.
| TruBridge, Inc. | |||||||||||||||
| Condensed Consolidated Statements of Income | |||||||||||||||
| (In '000s, except per share data) | |||||||||||||||
| (Unaudited) | |||||||||||||||
Three Months Ended September 30, |
| Nine Months Ended September 30, | |||||||||||||
2024 |
| 2023 |
| 2024 |
| 2023 | |||||||||
| Revenues | |||||||||||||||
| Financial Health | $ | 54,271 |
| $ | 46,582 |
| $ | 161,417 |
| $ | 142,973 |
| |||
| Patient Care |
| 29,559 |
|
| 36,130 |
|
| 90,389 |
|
| 110,594 |
| |||
| Total revenues |
| 83,830 |
|
| 82,712 |
|
| 251,806 |
|
| 253,567 |
| |||
| Expenses | |||||||||||||||
| Costs of revenue (exclusive of amortization and depreciation) | |||||||||||||||
| Financial Health |
| 29,185 |
|
| 27,159 |
|
| 89,051 |
|
| 81,461 |
| |||
| Patient Care |
| 13,184 |
|
| 16,704 |
|
| 38,421 |
|
| 50,712 |
| |||
| Total costs of revenue (exclusive of amortization and depreciation) |
| 42,369 |
|
| 43,863 |
|
| 127,472 |
|
| 132,173 |
| |||
| Product development |
| 7,735 |
|
| 9,778 |
|
| 26,629 |
|
| 26,899 |
| |||
| Sales and marketing |
| 5,944 |
|
| 6,818 |
|
| 20,351 |
|
| 21,906 |
| |||
| General and administrative |
| 19,376 |
|
| 20,961 |
|
| 57,651 |
|
| 54,471 |
| |||
| Amortization |
| 6,183 |
|
| 6,208 |
|
| 21,158 |
|
| 17,549 |
| |||
| Depreciation |
| 279 |
|
| 297 |
|
| 1,079 |
|
| 1,392 |
| |||
| Total expenses |
| 81,886 |
|
| 87,925 |
|
| 254,340 |
|
| 254,390 |
| |||
| Operating income (loss) |
| 1,944 |
|
| (5,213 | ) |
| (2,534 | ) |
| (823 | ) | |||
| Other income (expense): | |||||||||||||||
| Other income (expense) |
| (376 | ) |
| 224 |
|
| 1,139 |
|
| 569 |
| |||
| Interest expense |
| (4,033 | ) |
| (3,071 | ) |
| (12,348 | ) |
| (8,405 | ) | |||
| Total other expense |
| (4,409 | ) |
| (2,847 | ) |
| (11,209 | ) |
| (7,836 | ) | |||
| Loss before taxes |
| (2,465 | ) |
| (8,060 | ) |
| (13,743 | ) |
| (8,659 | ) | |||
| Income tax expense (benefit) |
| 7,344 |
|
| (4,498 | ) |
| 3,631 |
|
| (5,344 | ) | |||
| Net loss | $ | (9,809 | ) | $ | (3,562 | ) | $ | (17,374 | ) | $ | (3,315 | ) | |||
| Net loss per common share—basic | $ | (0.66 | ) | $ | (0.24 | ) | $ | (1.17 | ) | $ | (0.23 | ) | |||
| Net loss per common share—diluted | $ | (0.66 | ) | $ | (0.24 | ) | $ | (1.17 | ) | $ | (0.23 | ) | |||
| Weighted average shares outstanding used in per common share computations: | |||||||||||||||
| Basic |
| 14,323 |
|
| 14,205 |
|
| 14,290 |
|
| 14,181 |
| |||
| Diluted |
| 14,323 |
|
| 14,205 |
|
| 14,290 |
|
| 14,181 |
|
| TruBridge, Inc. | |||||||
| Condensed Consolidated Balance Sheets | |||||||
| (In '000s, except per share data) | |||||||
| September 30, 2024 (Unaudited) | Dec. 31, 2023 | ||||||
| Assets | |||||||
| Current assets | |||||||
| Cash and cash equivalents | $ | 8,586 |
| $ | 3,848 |
| |
| Accounts receivable, net of allowance for expected credit losses of $3,896 and $3,631, respectively |
| 56,680 |
|
| 59,723 |
| |
| Financing receivables, current portion (net of allowance for expected credit losses of $405 and $319, respectively) |
| 5,133 |
|
| 3,997 |
| |
| Inventories |
| 924 |
|
| 475 |
| |
| Prepaid income taxes |
| 1,972 |
|
| 1,628 |
| |
| Prepaid expenses and other |
| 15,853 |
|
| 15,807 |
| |
| Assets of held for sale |
| 2,473 |
|
| 25,977 |
| |
| Total current assets |
| 91,621 |
|
| 111,455 |
| |
| Property & equipment, net |
| 5,049 |
|
| 8,974 |
| |
| Software development costs, net |
| 41,026 |
|
| 39,139 |
| |
| Operating lease assets |
| 3,451 |
|
| 5,192 |
| |
| Financing receivables, net of current portion (net of allowance for expected credit losses of $18 and $97, respectively) |
| 231 |
|
| 1,226 |
| |
| Other assets, net of current portion |
| 7,749 |
|
| 7,314 |
| |
| Intangible assets, net |
| 79,833 |
|
| 89,213 |
| |
| Goodwill |
| 172,573 |
|
| 171,909 |
| |
| Total assets | $ | 401,533 |
| $ | 434,422 |
| |
| Liabilities & Stockholders' Equity | |||||||
| Current liabilities | |||||||
| Accounts payable | $ | 14,028 |
| $ | 10,133 |
| |
| Current portion of long-term debt |
| 2,926 |
|
| 3,141 |
| |
| Deferred revenue |
| 10,235 |
|
| 8,677 |
| |
| Accrued vacation |
| 5,392 |
|
| 5,410 |
| |
| Other accrued liabilities |
| 18,421 |
|
| 19,892 |
| |
| Liabilities of held for sale |
| - |
|
| 977 |
| |
| Total current liabilities |
| 51,002 |
|
| 48,230 |
| |
| Long-term debt, net of current portion |
| 173,343 |
|
| 195,270 |
| |
| Operating lease liabilities, net of current portion |
| 2,520 |
|
| 3,074 |
| |
| Deferred tax liabilities |
| 2,021 |
|
| 1,230 |
| |
| Total liabilities |
| 228,886 |
|
| 247,804 |
| |
| Stockholders' Equity | |||||||
| Common stock, $0.001 par value; 30,000 shares authorized; 15,546 and 15,121 shares issued, respectively |
| 15 |
|
| 15 |
| |
| Additional paid-in capital |
| 199,244 |
|
| 195,546 |
| |
| Accumulated other comprehensive gain |
| 107 |
|
| - |
| |
| Accumulated (deficit) earnings |
| (9,242 | ) |
| 8,132 |
| |
| Treasury stock, 619 and 572 shares, respectively |
| (17,477 | ) |
| (17,075 | ) | |
| Total stockholders' equity |
| 172,647 |
|
| 186,618 |
| |
| Total liabilities and stockholders' equity | $ | 401,533 |
| $ | 434,422 |
|
| TruBridge, Inc. | |||||||
| Condensed Consolidated Statements of Cash Flows | |||||||
| (In '000s) | |||||||
| (Unaudited) | |||||||
Nine Months Ended September 30, | |||||||
2024 | 2023 | ||||||
| Operating activities: | |||||||
| Net loss | $ | (17,374 | ) | $ | (3,315 | ) | |
| Adjustments to net loss: | |||||||
| Provision for credit losses |
| 1,046 |
|
| 810 |
| |
| Deferred taxes |
| 915 |
|
| (8,171 | ) | |
| Stock-based compensation |
| 3,698 |
|
| 2,162 |
| |
| Depreciation |
| 1,079 |
|
| 1,392 |
| |
| Gain on sale of business |
| (1,221 | ) |
| - |
| |
| Amortization of acquisition-related intangibles |
| 9,379 |
|
| 12,043 |
| |
| Amortization of software development costs |
| 11,779 |
|
| 5,506 |
| |
| Amortization of deferred finance costs |
| 320 |
|
| 269 |
| |
| Change in fair value of contingent consideration |
| (1,044 | ) |
| - |
| |
| Non-cash operating lease costs |
| 1,879 |
|
| 1,478 |
| |
| Loss on disposal of property and equipment |
| 1,648 |
|
| 117 |
| |
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable |
| 2,946 |
|
| (8,632 | ) | |
| Financing receivables |
| (129 | ) |
| 2,029 |
| |
| Inventories |
| (449 | ) |
| (157 | ) | |
| Prepaid expenses and other |
| 3,228 |
|
| (1,972 | ) | |
| Accounts payable |
| 3,925 |
|
| 6,333 |
| |
| Deferred revenue |
| 2,162 |
|
| (2,784 | ) | |
| Operating lease liabilities |
| (1,415 | ) |
| (1,462 | ) | |
| Other liabilities |
| (189 | ) |
| 6,656 |
| |
| Prepaid income taxes |
| (344 | ) |
| 1,017 |
| |
| Net cash provided by operating activities |
| 21,839 |
|
| 13,319 |
| |
| Investing activities: | |||||||
| Purchase of business, net of cash acquired |
| (664 | ) |
| - |
| |
| Sale of business, net of cash and cash equivalents sold |
| 21,410 |
|
| - |
| |
| Investment in software development |
| (13,666 | ) |
| (17,981 | ) | |
| Purchases of property and equipment |
| (1,277 | ) |
| (332 | ) | |
| Net cash provided by (used in) investing activities |
| 5,803 |
|
| (18,313 | ) | |
| Financing activities: | |||||||
| Payments of long-term debt principal |
| (6,625 | ) |
| (2,625 | ) | |
| Proceeds from revolving line of credit |
| 23,765 |
|
| 9,716 |
| |
| Payments of revolving line of credit |
| (39,072 | ) |
| (5,000 | ) | |
| Debt issuance costs |
| (529 | ) |
| - |
| |
| Treasury stock purchases |
| (402 | ) |
| (2,575 | ) | |
| Net cash used in financing activities |
| (22,863 | ) |
| (484 | ) | |
| Increase (decrease) in cash and cash equivalents |
| 4,779 |
|
| (5,478 | ) | |
| Change in cash and cash equivalents included in assets sold |
| (41 | ) |
| - |
| |
| Cash and cash equivalents, beginning of period |
| 3,848 |
|
| 6,951 |
| |
| Cash and cash equivalents, end of period | $ | 8,586 |
| $ | 1,473 |
|
| TruBridge, Inc. | ||||||||||
| Consolidated Bookings | ||||||||||
| (In '000s) | ||||||||||
| (Unaudited) (Non-GAAP) | ||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||
| 2024 |
| 2023 (3) |
| 2024 |
| 2023 (3) | |||
| Financial Health (1) | $ | 12,496 | $ | 9,080 | $ | 40,346 | $ | 34,828 | ||
| Patient Care (2) |
| 8,454 |
| 5,897 |
| 27,464 |
| 20,966 | ||
| Total | $ | 20,950 | $ | 14,977 | $ | 67,810 | $ | 55,794 | ||
(1) | Generally calculated as the total contract price (for non-recurring, project-related amounts) and annualized contract value (for recurring amounts). | |||||||||
(2) | Generally calculated as the total contract price (for system sales) and annualized contract value (for support) for perpetual license system sales and total contract price for SaaS sales. | |||||||||
(3) | Adjustment was made to the 2023 bookings, due to 3rd Party Software, and Forms and Supplies being doubled accounted for in the total Patient Care bookings. |
| TruBridge, Inc. | |||||||||||
| Bookings Composition | |||||||||||
| (In '000s, except per share data) | |||||||||||
| (Unaudited) (Non-GAAP) | |||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
2024 | 2023 (4) | 2024 | 2023 (4) | ||||||||
| Financial Health | |||||||||||
| Net new (1) | $ | 6,112 | $ | 4,387 | $ | 21,559 | $ | 13,810 | |||
| Cross-sell (1) |
| 6,384 |
| 4,693 |
| 18,787 |
| 21,018 | |||
| Patient Care | |||||||||||
| Non-subscription sales (2) |
| 5,006 |
| 3,126 |
| 12,540 |
| 12,124 | |||
| Subscription revenue (3) |
| 3,448 |
| 2,771 |
| 14,924 |
| 8,842 | |||
| Total | $ | 20,950 | $ | 14,977 | $ | 67,810 | $ | 55,794 | |||
(1) | “Net new” represents bookings from outside the Company’s core Patient Care client base, and “Cross-sell” represents bookings from existing Patient Care customers. In each case, such bookings are generally comprised of recurring revenues to be recognized ratably over a one-year period and an average timeframe for commencement of bookings-to-revenue conversion of four to six months following contract execution. | ||||||||||
(2) | Represents nonrecurring revenues that generally exhibit a timeframe for bookings-to-revenue conversion of five to six months following contract execution. | ||||||||||
(3) | Represents recurring revenues to be recognized on a monthly basis over a weighted-average contract period of five years, with a start date in the next 12 months and an average timeframe for commencement of bookings-to-revenue conversion of five to six months following contract execution. | ||||||||||
(4) | Adjustment was made to the 2023 bookings, due to 3rd Party Software, and Forms and Supplies being doubled accounted for in the total Patient Care bookings. |
| TruBridge, Inc. | ||||||||||
| Adjusted EBITDA - by Segment | ||||||||||
| (In '000s) | ||||||||||
| (Unaudited) (Non-GAAP) | ||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||
| In '000s | 2024 | 2023 | 2024 | 2023 | ||||||
| Financial Health | $ | 9,562 | $ | 4,623 | $ | 23,767 | $ | 18,205 | ||
| Patient Care |
| 4,260 |
| 5,099 |
| 12,083 |
| 17,388 | ||
| Total | $ | 13,822 | $ | 9,722 | $ | 35,850 | $ | 35,593 |
| TruBridge, Inc. | ||||||||||||||||
| Reconciliation of Non-GAAP Financial Measures | ||||||||||||||||
| (In '000s) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
Three Months Ended September 30, |
| Nine Months Ended September 30, | ||||||||||||||
| Adjusted EBITDA: | 2024 |
| 2023 |
| 2024 |
| 2023 | |||||||||
| Net loss, as reported | $ | (9,809 | ) | $ | (3,562 | ) | $ | (17,374 | ) | $ | (3,315 | ) | ||||
| Net Income Margin |
| (11.7 | %) |
| (4.3 | %) |
| (6.9 | %) |
| (1.3 | %) | ||||
| Depreciation expense |
| 279 |
|
| 297 |
|
| 1,079 |
|
| 1,392 |
| ||||
| Amortization of software development costs |
| 3,057 |
|
| 2,194 |
|
| 11,779 |
|
| 5,506 |
| ||||
| Amortization of acquisition-related intangibles |
| 3,126 |
|
| 4,014 |
|
| 9,379 |
|
| 12,043 |
| ||||
| Stock-based compensation |
| 1,398 |
|
| 1,038 |
|
| 3,698 |
|
| 2,162 |
| ||||
| Severance and other non-recurring charges |
| 4,018 |
|
| 7,392 |
|
| 12,449 |
|
| 15,313 |
| ||||
| Interest expense |
| 3,777 |
|
| 2,847 |
|
| 11,826 |
|
| 7,719 |
| ||||
| Change in fair value of contingent consideration |
| (1,044 | ) |
| - |
|
| (1,044 | ) |
| - |
| ||||
| Loss on disposal of property and equipment |
| 1,648 |
|
| - |
|
| 1,648 |
|
| 117 |
| ||||
| Gain on sale of AHT |
| 28 |
|
| - |
|
| (1,221 | ) |
| - |
| ||||
| Provision (benefit) for income taxes |
| 7,344 |
|
| (4,498 | ) |
| 3,631 |
|
| (5,344 | ) | ||||
| Total Adjusted EBITDA | $ | 13,822 |
| $ | 9,722 |
| $ | 35,850 |
| $ | 35,593 |
| ||||
| Adjusted EBITDA Margin |
| 16.5 | % |
| 11.8 | % |
| 14.2 | % |
| 14.0 | % |
| TruBridge, Inc. | ||||||||||||
| Reconciliation of Non-GAAP Financial Measures | ||||||||||||
| (In '000s, except per share data) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||
| Non-GAAP Net Income (loss) and Non-GAAP EPS: |
| 2024 |
|
| 2023 |
|
| 2024 |
|
| 2023 |
|
| Net loss, as reported | $ | (9,809 | ) | $ | (3,562 | ) | $ | (17,374 | ) | $ | (3,315 | ) |
| Pre-tax adjustments for Non-GAAP EPS: | ||||||||||||
| Amortization of acquisition-related intangible assets |
| 3,126 |
|
| 4,014 |
|
| 9,379 |
|
| 12,043 |
|
| Stock-based compensation |
| 1,398 |
|
| 1,038 |
|
| 3,698 |
|
| 2,162 |
|
| Severance and other nonrecurring charges |
| 4,018 |
|
| 7,392 |
|
| 12,449 |
|
| 15,313 |
|
| Non-cash interest expense |
| 107 |
|
| 90 |
|
| 314 |
|
| 270 |
|
| After-tax adjustments for Non-GAAP EPS: | ||||||||||||
| Tax-effect of pre-tax adjustments, at 21% |
| (1,816 | ) |
| (2,632 | ) |
| (5,426 | ) |
| (6,255 | ) |
| Tax shortfall (windfall) from stock-based compensation |
| 13 |
|
| 8 |
|
| 126 |
|
| 65 |
|
| Non-GAAP net income (loss) | $ | (2,963 | ) | $ | 6,348 |
| $ | 3,166 |
| $ | 20,283 |
|
| Weighted average shares outstanding, diluted |
| 14,323 |
|
| 14,205 |
|
| 14,290 |
|
| 14,181 |
|
| Non-GAAP EPS | $ | (0.21 | ) | $ | 0.45 |
| $ | 0.22 |
| $ | 1.43 |
|
| TruBridge, Inc. | ||||||||
| Patient Care Revenue Composition | ||||||||
| (In '000s) | ||||||||
| (Unaudited) | ||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
| Recurring revenues - Patient Care | ||||||||
| Acute care | $ | 26,584 | $ | 29,068 | $ | 80,726 | $ | 88,420 |
| Post-acute care |
| - |
| 3,594 |
| 597 |
| 11,230 |
| Total recurring revenues - Patient Care |
| 26,584 |
| 32,662 |
| 81,323 |
| 99,650 |
| Non-recurring revenues - Patient Care | ||||||||
| Acute care |
| 2,975 |
| 3,118 |
| 8,996 |
| 9,869 |
| Post-acute care |
| - |
| 350 |
| 70 |
| 1,075 |
| Total non-recurring revenues - Patient Care |
| 2,975 |
| 3,468 |
| 9,066 |
| 10,944 |
| Total Patient Care revenues | $ | 29,559 | $ | 36,130 | $ | 90,389 | $ | 110,594 |
Explanation of Non-GAAP Financial Measures
We report our financial results in accordance with accounting principles generally accepted in the United States of America, or “GAAP.” However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures that are prepared in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management uses these non-GAAP financial measures in order to evaluate the operating performance of the Company and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. In addition, management understands that some investors and financial analysts find these non-GAAP financial measures helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.
As such, to supplement the GAAP information provided, we present in this press release and during the live webcast discussing our financial results the following non-GAAP financial measures: Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net income, and Non-GAAP earnings per share (“EPS”).
We calculate each of these non-GAAP financial measures as follows:
Certain of the items excluded or adjusted to arrive at these non-GAAP financial measures are described below:
Management considers these non-GAAP financial measures to be important indicators of our operational strength and performance of our business and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial performance. In addition, management may use Adjusted EBITDA, Non-GAAP net income and/or Non-GAAP EPS to measure the achievement of performance objectives under the Company’s stock and cash incentive programs. Note, however, that these non-GAAP financial measures are performance measures only, and they do not provide any measure of cash flow or liquidity. Non-GAAP financial measures are not alternatives for measures of financial performance prepared in accordance with GAAP and may be different from similarly titled non-GAAP measures presented by other companies, limiting their usefulness as comparative measures. Non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Additionally, there is no certainty that we will not incur expenses in the future that are similar to those excluded in the calculations of the non-GAAP financial measures presented in this press release. Investors and potential investors are encouraged to review the “Unaudited Reconciliation of Non-GAAP Financial Measures” above.
View source version on businesswire.com:https://www.businesswire.com/news/home/20241107152480/en/
CONTACT: Investor Relations Contact
Asher Dewhurst, ICR Westwicke
TBRGIR@westwicke.comMedia Contact
Tracey Schroeder
Chief Marketing Officer
Tracey.schroeder@trubridge.com
KEYWORD: ALABAMA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SOFTWARE PRACTICE MANAGEMENT DATA ANALYTICS HEALTH HOSPITALS HEALTH TECHNOLOGY PROFESSIONAL SERVICES TECHNOLOGY
SOURCE: TruBridge, Inc.
Copyright Business Wire 2024.
PUB: 11/07/2024 05:00 PM/DISC: 11/07/2024 04:59 PM
http://www.businesswire.com/news/home/20241107152480/en